Investigating how a specific enzyme affects inflammation in the heart after a heart attack

The role of ATP citrate lyase in cardiac macrophage-mediated inflammation aftermyocardial infarction

NIH-funded research Veterans Health Administration · NIH-10925500

This study is looking at how a specific enzyme in the heart affects inflammation after a heart attack, which could help us understand why some people have more heart problems afterward, and it aims to find ways to help those patients feel better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Pittsburgh, United States)
Project IDNIH-10925500 on NIH RePORTER

What this research studies

This research focuses on understanding the role of ATP citrate lyase (ACLY) in the inflammation that occurs in the heart following a myocardial infarction (heart attack). The study aims to explore how this enzyme influences the behavior of macrophages, a type of immune cell, and whether it contributes to increased inflammation and heart damage. By examining the metabolic pathways and epigenetic changes in cardiac macrophages, the research seeks to uncover mechanisms that lead to complications like heart failure. Patients who have experienced a heart attack may benefit from insights gained through this investigation.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have recently suffered a myocardial infarction, particularly those with ongoing inflammation or complications.

Not a fit: Patients who have not experienced a myocardial infarction or those with unrelated cardiac conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that reduce inflammation and improve recovery outcomes for heart attack patients.

How similar studies have performed: Previous studies have shown that targeting inflammation can significantly improve outcomes in heart attack patients, suggesting that this approach may yield valuable insights.

Where this research is happening

Pittsburgh, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.